Skip to main content


Fig. 2 | BMC Cell Biology

Fig. 2

From: Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma

Fig. 2

Heterogeneous cell death induction in melanoma cells treated with dasatinib, alone or in combination with dacarbazine. a Cell death responsiveness (propidium iodide positivity) of melanoma cell lines after single and combination treatment with dasatinib and dacarbazine (72 h). Bars represent mean values from three independent experiments, each run with triplicate samples. Error bars show SEM. b Summary table of cell death data from (a)

Back to article page